NSETrading Window23 Jun 2026 · 23 Jun 2026, 06:53 pm
Trading Window
Brooks Laboratories Limited · BROOKS
✦ AI Summary
Brooks Laboratories Limited announced the closure of its trading window for Designated Persons and their immediate relatives, effective July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting and the opening of the trading window will be communicated later.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Brooks Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
BROOKS_23062026185247_CTW.pdf
View document text
Date : 23rd June 2026
BSE Limited National Stock Exchange of India Ltd.
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex
Mumbai-400001 Bandra (E), Mumbai-400051
Stock Symbol-533543 Scrip Code- BROOKS
Sub: Intimation of Closure of Trading Window
Dear Sir/Madam,
As per the Securities and Exchange Board of India (Prohibition of Insider Trading) (Second Amendment)
Regulation, 2019, effective from July 25, 2019, and pursuant to Company’s Code of Conduct for prevention
of Insider Trading, the ‘Trading Restriction Period’ shall be made applicable from the end of every quarter
till 48 hours after the declaration of Financial Results.
In view of the aforesaid, it is hereby intimated that the Trading Window for dealing in the securities of the
Company will be closed for the Designated Persons and their immediate relatives effective from
Wednesday, 1st July, 2026, until 48 hours after the declaration of Unaudited Financial Results (Standalone
and Consolidated) for the quarter ended 30th June, 2026. The details of the Board Meeting and opening
of the Trading Window shall be intimated in due course.
The same has been informed to Designated Persons in accordance with the Code of Conduct. Please take
the above on records.
Yours faithfully
For BROOKS LABORATORIES LIMITED
Krutika Rane
Company Secretary and Compliance Officer
Membership no: A66310